10th anniversary of iPS cells: the challenges that lie ahead.
Level 5 - mechanism / opinion, no new human data
Narrative review and historical commentary without systematic methodology or primary human clinical data.
PubMed 27387749 · doi:10.1093/jb/mvw044
What was done
This narrative review commemorates the 10th anniversary of induced pluripotent stem (iPS) cell discovery in 2006. The authors summarize technological developments in iPS cell generation, mechanistic insights into cellular reprogramming, applications in drug discovery, disease modeling, and regenerative medicine, as well as ongoing challenges in cell qualification and differentiation.
What was found
The abstract reports no quantitative metrics or empirical experimental findings; it provides a high-level conceptual summary of historical milestones, applications, and future issues in iPS cell biology.
Why it matters
It outlines the initial decade of progress and remaining translational hurdles in iPS cell research for regenerative medicine and pharmacological screening.
Limits
As a non-systematic narrative review and commentary, it does not provide new empirical data, quantitative synthesis, or formal evaluation of study quality across cited literature.
Cited by
- supports The Yamanaka factors, which allow reprograming a somatic cell into an induced pluripotent stem cell, were discovered in 2006.